NCT03656887

Brief Summary

Diabetes is a major public health problem that has been growing steadily in recent years. Its prevalence is very high in the elderly, in whom there is an increased risk of hypoglycemia. Hypoglycaemia in elderly diabetics has serious consequences:

  • increased mortality,
  • increased cardiovascular morbidity,
  • increased risk of falling,
  • impairment of quality of life.
  • Hypoglycaemia is also a risk factor for dementia in type 2 diabetes. The frequency of asymptomatic and atypical hypoglycemia has been shown to be greater in the elderly, but the exact prevalence of hypoglycemia in the elderly remains unknown. Elderly diabetic patients in institutions are particularly fragile and have more frequent cognitive problems than non-diabetic subjects. A study conducted in this population of patients showed that a third of them had HbA1C \<6.5%, which suggests a higher frequency of hypoglycemia though the figures were not available. We therefore decided to conduct a study to assess the frequency of hypoglycemia in order to better understand the contributing factors and to improve the management of this fragile population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 4, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

January 8, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2019

Completed
Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

August 31, 2018

Last Update Submit

February 2, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of hypoglycemic events (<70 mg/dl) demonstrated by continuous interstitial glucose monitoring over the study period.

    Day 14

  • Number of hypoglycemic events (<70 mg/dl) detected by capillary blood glucose measurement or clinical signs suggestive of hypoglycemia.

    Day 14

Interventions

Installing and removing the sensor

Scan of the sensor, using the Freestyle Pro free version reader, at installation then before removal after 14 days.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient institutionalized in EHPAD

You may qualify if:

  • written consent
  • diabetic patient receiving treatment which could result in hypoglycemia: insulin and/or sulfonamide and/or glinides
  • institutionalized patient in an EHPAD
  • patient over 60 years of age

You may not qualify if:

  • \- person not affiliated to a national health insurance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Dijon Bourogne

Dijon, 21000, France

Location

Related Publications (1)

  • Bouillet B, Tscherter P, Vaillard L, Nonciaux C, Hourdain P, Ravier A, Rouland A, Petit JM, Verges B, Quilot E. Frequent and severe hypoglycaemia detected with continuous glucose monitoring in older institutionalised patients with diabetes. Age Ageing. 2021 Nov 10;50(6):2088-2093. doi: 10.1093/ageing/afab128.

MeSH Terms

Conditions

Diabetes MellitusHypoglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2018

First Posted

September 4, 2018

Study Start

January 8, 2019

Primary Completion

June 11, 2019

Study Completion

June 11, 2019

Last Updated

February 4, 2026

Record last verified: 2026-02

Locations